top of page
  • Pyxis Partners

Pyxis Partners congratulates Senator Tammy Baldwin

Pyxis Partners congratulates Senator Tammy Baldwin on being named Chair of Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.

Throughout her 35 years in public service, Senator Tammy Baldwin has made expanding access to quality affordable health care her priority. As the Fiscal Year 2024 budget and appropriations season gets underway, we congratulate her on being named Chair of the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education.

“Tammy Baldwin is an unwavering champion of healthcare access, affordability and equity for all Americans,” said Bill Murat, former Chief of Staff to Senator Baldwin, who led her team for 21 years. “Her immeasurable contributions to our healthcare system have impacted the lives of millions of Americans. This new leadership role provides Senator Baldwin with a great opportunity to build on her previous accomplishments.”

“I am proud to have known and worked with Sen. Baldwin for more than 20 years,” said Michael Manganiello, President and CEO, Pyxis Partners. “I am honored to have worked with Chairwoman Baldwin on the passage of the Christopher and Dana Reeve Paralysis Act in 2009 – the first legislation specific to the paralysis community - in her role as co-sponsor of this important piece of legislation that focused on the care and cure of Americans living with spinal cord injuries and paralysis,” he continued.

“As a passionate advocate for funding that expands affordable health coverage, including mental health coverage, supports efforts to combat opioid and fentanyl abuse and invests in medical research, we look forward to her continued strong leadership, passion and conviction to improve the health and wellbeing of all Americans." Manganiello added, " I am thrilled that Bill Murat, Senator Baldwin's former COS, now advises Pyxis as Senior Counsel on all matters having to do with health equity particularly as it applies to health care and diversity in clinical research. ”

bottom of page